OPTN/SRTR 2011 Annual Data Report: Lung

M. Valapour, K. Paulson, J. M. Smith, Marshall I Hertz, M. A. Skeans, B. M. Heubner, L. B. Edwards, J. J. Snyder, A. K. Israni, Bert L Kasiske

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Lungs are allocated in part based on the Lung Allocation Score (LAS), which considers risk of death without transplant and posttransplant. Wait-list addi-tions have been increasing steadily after an initial decline following LAS implementa-tion. In 2011, the largest number of adult candidates were added to the waiting list in a single year since 1998; donation and transplant rates have been unable to keep pace with wait-list additions. Candidates aged 65 years or older have been added faster than candidates in other age groups. After an initial decline following LAS implemen-tation, wait-list mortality increased to 15.7 per 100 wait-list years in 2011. Short- and long-term graft survival improved in 2011; 10-year graft failure fell to an all-time low. Since 1998, the number of new pediatric (aged 0-11 years) candidates added yearly to the waiting list has declined. In 2011, 19 pediatric lung transplants were performed, a transplant rate of 34.7 per 100 wait-list years. The percentage of patients hospitalized before transplant has not changed. Both graft and patient survival have continued to improve over the past decade. Posttransplant complications for pediatric lung trans-plant recipients, similar to complications for adult recipients, include hypertension, renal dysfunction, diabetes, bronchiolitis obliterans syndrome, and malignancy.

Original languageEnglish (US)
Pages (from-to)149-177
Number of pages29
JournalAmerican Journal of Transplantation
Volume13
Issue numberSUPPL. 1
DOIs
StatePublished - Dec 1 2013

Fingerprint

Annual Reports
Transplants
Lung
Waiting Lists
Graft Survival
Pediatrics
Bronchiolitis Obliterans
Renal Hypertension
Age Groups
Mortality
Neoplasms

Keywords

  • End-stage lung diseases
  • Lung Allocation Score
  • Lung transplant
  • Transplant outcomes

Cite this

Valapour, M., Paulson, K., Smith, J. M., Hertz, M. I., Skeans, M. A., Heubner, B. M., ... Kasiske, B. L. (2013). OPTN/SRTR 2011 Annual Data Report: Lung. American Journal of Transplantation, 13(SUPPL. 1), 149-177. https://doi.org/10.1111/ajt.12024

OPTN/SRTR 2011 Annual Data Report : Lung. / Valapour, M.; Paulson, K.; Smith, J. M.; Hertz, Marshall I; Skeans, M. A.; Heubner, B. M.; Edwards, L. B.; Snyder, J. J.; Israni, A. K.; Kasiske, Bert L.

In: American Journal of Transplantation, Vol. 13, No. SUPPL. 1, 01.12.2013, p. 149-177.

Research output: Contribution to journalArticle

Valapour, M, Paulson, K, Smith, JM, Hertz, MI, Skeans, MA, Heubner, BM, Edwards, LB, Snyder, JJ, Israni, AK & Kasiske, BL 2013, 'OPTN/SRTR 2011 Annual Data Report: Lung', American Journal of Transplantation, vol. 13, no. SUPPL. 1, pp. 149-177. https://doi.org/10.1111/ajt.12024
Valapour M, Paulson K, Smith JM, Hertz MI, Skeans MA, Heubner BM et al. OPTN/SRTR 2011 Annual Data Report: Lung. American Journal of Transplantation. 2013 Dec 1;13(SUPPL. 1):149-177. https://doi.org/10.1111/ajt.12024
Valapour, M. ; Paulson, K. ; Smith, J. M. ; Hertz, Marshall I ; Skeans, M. A. ; Heubner, B. M. ; Edwards, L. B. ; Snyder, J. J. ; Israni, A. K. ; Kasiske, Bert L. / OPTN/SRTR 2011 Annual Data Report : Lung. In: American Journal of Transplantation. 2013 ; Vol. 13, No. SUPPL. 1. pp. 149-177.
@article{3186f59b0c0848878ed420643e047a3c,
title = "OPTN/SRTR 2011 Annual Data Report: Lung",
abstract = "Lungs are allocated in part based on the Lung Allocation Score (LAS), which considers risk of death without transplant and posttransplant. Wait-list addi-tions have been increasing steadily after an initial decline following LAS implementa-tion. In 2011, the largest number of adult candidates were added to the waiting list in a single year since 1998; donation and transplant rates have been unable to keep pace with wait-list additions. Candidates aged 65 years or older have been added faster than candidates in other age groups. After an initial decline following LAS implemen-tation, wait-list mortality increased to 15.7 per 100 wait-list years in 2011. Short- and long-term graft survival improved in 2011; 10-year graft failure fell to an all-time low. Since 1998, the number of new pediatric (aged 0-11 years) candidates added yearly to the waiting list has declined. In 2011, 19 pediatric lung transplants were performed, a transplant rate of 34.7 per 100 wait-list years. The percentage of patients hospitalized before transplant has not changed. Both graft and patient survival have continued to improve over the past decade. Posttransplant complications for pediatric lung trans-plant recipients, similar to complications for adult recipients, include hypertension, renal dysfunction, diabetes, bronchiolitis obliterans syndrome, and malignancy.",
keywords = "End-stage lung diseases, Lung Allocation Score, Lung transplant, Transplant outcomes",
author = "M. Valapour and K. Paulson and Smith, {J. M.} and Hertz, {Marshall I} and Skeans, {M. A.} and Heubner, {B. M.} and Edwards, {L. B.} and Snyder, {J. J.} and Israni, {A. K.} and Kasiske, {Bert L}",
year = "2013",
month = "12",
day = "1",
doi = "10.1111/ajt.12024",
language = "English (US)",
volume = "13",
pages = "149--177",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - OPTN/SRTR 2011 Annual Data Report

T2 - Lung

AU - Valapour, M.

AU - Paulson, K.

AU - Smith, J. M.

AU - Hertz, Marshall I

AU - Skeans, M. A.

AU - Heubner, B. M.

AU - Edwards, L. B.

AU - Snyder, J. J.

AU - Israni, A. K.

AU - Kasiske, Bert L

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Lungs are allocated in part based on the Lung Allocation Score (LAS), which considers risk of death without transplant and posttransplant. Wait-list addi-tions have been increasing steadily after an initial decline following LAS implementa-tion. In 2011, the largest number of adult candidates were added to the waiting list in a single year since 1998; donation and transplant rates have been unable to keep pace with wait-list additions. Candidates aged 65 years or older have been added faster than candidates in other age groups. After an initial decline following LAS implemen-tation, wait-list mortality increased to 15.7 per 100 wait-list years in 2011. Short- and long-term graft survival improved in 2011; 10-year graft failure fell to an all-time low. Since 1998, the number of new pediatric (aged 0-11 years) candidates added yearly to the waiting list has declined. In 2011, 19 pediatric lung transplants were performed, a transplant rate of 34.7 per 100 wait-list years. The percentage of patients hospitalized before transplant has not changed. Both graft and patient survival have continued to improve over the past decade. Posttransplant complications for pediatric lung trans-plant recipients, similar to complications for adult recipients, include hypertension, renal dysfunction, diabetes, bronchiolitis obliterans syndrome, and malignancy.

AB - Lungs are allocated in part based on the Lung Allocation Score (LAS), which considers risk of death without transplant and posttransplant. Wait-list addi-tions have been increasing steadily after an initial decline following LAS implementa-tion. In 2011, the largest number of adult candidates were added to the waiting list in a single year since 1998; donation and transplant rates have been unable to keep pace with wait-list additions. Candidates aged 65 years or older have been added faster than candidates in other age groups. After an initial decline following LAS implemen-tation, wait-list mortality increased to 15.7 per 100 wait-list years in 2011. Short- and long-term graft survival improved in 2011; 10-year graft failure fell to an all-time low. Since 1998, the number of new pediatric (aged 0-11 years) candidates added yearly to the waiting list has declined. In 2011, 19 pediatric lung transplants were performed, a transplant rate of 34.7 per 100 wait-list years. The percentage of patients hospitalized before transplant has not changed. Both graft and patient survival have continued to improve over the past decade. Posttransplant complications for pediatric lung trans-plant recipients, similar to complications for adult recipients, include hypertension, renal dysfunction, diabetes, bronchiolitis obliterans syndrome, and malignancy.

KW - End-stage lung diseases

KW - Lung Allocation Score

KW - Lung transplant

KW - Transplant outcomes

UR - http://www.scopus.com/inward/record.url?scp=84875146206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875146206&partnerID=8YFLogxK

U2 - 10.1111/ajt.12024

DO - 10.1111/ajt.12024

M3 - Article

C2 - 23237700

AN - SCOPUS:84875146206

VL - 13

SP - 149

EP - 177

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - SUPPL. 1

ER -